Leaflet: Information for the User
RamiprilKrka10 mg Tablets EFG
Read this leaflet carefully before you start taking the medicine, as it contains important information for you.
1.What is Ramipril Krka and what it is used for
2.What you need to know before taking Ramipril Krka
3.How to take Ramipril Krka
4.Possible side effects
5Storage of Ramipril Krka
6.Contents of the pack and additional information
RamiprilKrkacontains the active ingredient ramipril. This belongs to a group of medicines called angiotensin-converting enzyme (ACE) inhibitors.
RamiprilKrka works in the following way:
RamiprilKrka may be used:
Do not takeRamiprilKrka
The symptoms of an allergic reaction may include skin rash, difficulty swallowing or breathing, swelling of your lips, face, throat or tongue.
-if you have ever had a severe allergic reaction called“angioedema”. The symptoms include itching, urticaria, red patches on your hands, feet and throat, swelling of your throat and tongue, swelling around your eyes and lips, difficulty breathing and swallowing.
-if you are undergoing dialysis or any other type of blood filtration. Depending on the machine used, RamiprilKrkamay not be suitable for you.
-if you have kidney problems when your blood flow to your kidneys is reduced (renal artery stenosis).
Do not takeRamiprilKrkaif any of the above conditions apply to you. If you are unsure, speak to your doctor before takingRamiprilKrka.
Warnings and precautions
Consult your doctor or pharmacist before starting to take RamiprilKrka:
Your doctor may need to monitor your renal function, blood pressure and electrolyte levels in your blood (e.g. potassium) at regular intervals.
See also the information under the heading “Do not takeRamiprilKrka”.
You must inform your doctor if you are (or may be) pregnant. Ramipril is not recommended in the first 3 months of pregnancy and may cause serious harm to your baby if used after 3 months of pregnancy (see below the section “Pregnancy and Breastfeeding”).
Children and adolescents
RamiprilKrkais not recommended for use in children and adolescents under 18 years of age because the safety and efficacy of RamiprilKrkain children have not yet been established.
If any of the above conditions apply to you (or you are unsure), speak to your doctor before takingRamiprilKrka.
Use of RamiprilKrkawith other medicines
Inform your doctor or pharmacist that you are using, have used recently or may need to take any other medicine, including non-prescription medicines (including herbal medicines). This is because Ramipril HCSmay affect the way other medicines work. Similarly, some medicines may affect the wayRamiprilKrkaworks.
Inform your doctor if you are taking any of the following medicines. They may make Ramipril work less effectively:
Inform your doctor if you are taking any of the following medicines. They may increase the risk of side effects if taken withRamiprilKrka:
Inform your doctor if you are taking any of the following medicines. They may be affected byRamiprilKrka:
If any of the above conditions apply to you (or you are unsure), speak to your doctor before takingRamiprilKrka.
Your doctor may need to modify your dose and/or take other precautions:
Taking RamiprilKrkawith food and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medicine.
Pregnancy
You must inform your doctor if you are pregnant (or suspect that you may be). Do not take RamiprilKrkain the first 12 weeks of pregnancy and do not take it until after week 13 as its use during pregnancy may cause harm to your baby.
If you become pregnant while taking RamiprilKrka, inform your doctor immediately. Before a planned pregnancy, you should change to an alternative suitable treatment.
Breastfeeding
You must not take RamiprilKrkaif you are breastfeeding.
Ask your doctor or pharmacist for advice before taking any medicine.
Driving and operating machines
You may feel drowsy or dizzy while taking RamiprilKrka. This is more likely to occur when you first start taking RamiprilKrkaor when you start taking a higher dose of Ramipril HCS. If this occurs, do not drive or operate tools or machines.
Ramipril Krka contains sodium
This medicine contains less than 23 mg of sodium (1mmol) per tablet; this is, essentially “sodium-free”.
Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. Consult your doctor or pharmacist if you have doubts.
Medication intake
How much medication to take
Hypertension treatment
To reduce the risk of suffering a heart attack or stroke
Treatment to reduce or delay the worsening of kidney problems
Heart failure treatment
Treatment after a heart attack
Older patients
Your doctor will reduce the initial dose and adjust your treatment more slowly.
If you take more RamiprilKrkathan you should
Consult your doctor immediately or go to the nearest hospital emergency department, accompanied by this leaflet. Do not drive to the hospital, ask someone to take you or call an ambulance. Bring the packaging of the medication with you. This way your doctor will know what you have taken.
You can also call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount ingested.
If you forgot to take RamiprilKrka
If you interrupt treatment with RamiprilKrka
Continue taking your medication until your doctor tells you to. Do not stop taking Ramipril HCS even if you feel better. If you interrupt treatment, your disease may return.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Stop taking Ramipril Krka and seek immediate medical attention if you notice any of the following severe side effects – you may need urgent medical treatment:
Inform your doctor immediately if you experience:
Other side effects include:
Inform your doctor if any of the following worsen or last more than a few days.
Frequent (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 100 people)
Very rare (may affect up to 1 in 10,000 people)
Unknown (frequency cannot be estimated from available data)
Other side effects reported:
Inform your doctor if any of the following side effects worsen or last more than a few days.
Reporting of suspected adverse reactions
It is essential to report suspected adverse reactions to the medicine after its authorization. This allows for continuous monitoring of the benefit-risk ratio of the medicine. Healthcare professionals are invited to report suspected adverse reactions via the Spanish System for Pharmacovigilance of Medicines for Human Use:Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano:www.notificaram.es.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box, bottle label, and blister pack after CAD. The expiration date is the last day of the month indicated.
Do not store above 86°F (30°C).
Store in the original packaging to protect it from moisture.
Medicines should not be disposed of through drains or in the trash.Deposit the containers and medicines you no longer need at the SIGRE point of your pharmacy.If in doubt, ask your pharmacist how to dispose of the containers and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Ramipril Krka
The other components (excipients) arehypromellose 6cP, microcrystalline cellulose, pregelatinized cornstarch and sodium stearyl fumarate.See section 2 “Ramipril Krka Krka contains sodium”
Appearance of the product and contents of the pack
Tablet
Ramipril Krka 10 mg tablet, white to almost white, capsule-shaped with beveled edges, scored on both faces. One face is marked with a 10 on one half and KRK on the other half. Tablet dimensions: 8 x 5 mm. The tablet can be divided into equal doses.
Rampril Krka 10 mg is available in blisters (OPA/Al/PVC//Al): 20, 28, 30, 50 or 100 tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder
Krka, d.d., Novo mesto,
Šmarješka cesta 6, 8501 Novo mesto,
Slovenia.
Responsible for manufacturing
Krka, d.d., Novo mesto,
Šmarješka cesta 6, 8501 Novo mesto,
Slovenia.
Or
TAD Pharma GmbH, Heinz-Lohmann - Straße 5,
27472 Cuxhaven,
Germany
For more information about this medicine, please contact the local representative of the marketing authorization holder:
KRKA Farmacéutica, S.L., C/ Anabel Segura 10,Pta. Baja, Oficina 1,28108 Alcobendas, Madrid, Spain
This medicine is authorized in the member states of the European Economic Area with the following trade names:
Country | Trade name |
Malta | Ramipril TAD 10 mg |
Belgium | Ramipril Krka 10 mg tabletten |
Germany | Ramipril TAD10 mg Tabletten |
Last review date of this leaflet: May 2019
For detailed and updated information aboutthis medicine, please visit the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.